Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5127]

Breast-conserving therapy yields better 10-year outcomes than mastectomy for...

Dr Sabine Siesling - Netherlands Comprehensive Cancer Organisation, Utrecht...

Breast-conserving therapy yields better 10-year outcomes than mastectomy for early-stage patients ( Dr Sabine Siesling - Netherlands Comprehensive Cancer Organisation, Utrecht, Netherlands )

Adding carboplatin to presurgery chemotherapy improved disease-free survival...

Prof Gunter von Minckwitz - German Breast Group, Neu-Isenburg, Germany

Adding carboplatin to presurgery chemotherapy improved disease-free survival for patients with triple-negative breast cancer ( Prof Gunter von Minckwitz - German Breast Group, Neu-Isenburg, Germany )

Analysis of blood samples finds ESR1 gene mutations are prevalent and...

Dr Sarat Chanderlapaty - Memorial Sloan Kettering Cancer Center, New York, USA

Analysis of blood samples finds ESR1 gene mutations are prevalent and associated with worse overall survival ( Dr Sarat Chanderlapaty - Memorial Sloan Kettering Cancer Center, New York, USA )

Breast-conserving therapy yielded better outcomes than mastectomy for early...

Dr Sabine Siesling - Netherlands Comprehensive Cancer Organisation, Utrecht...

Breast-conserving therapy yielded better outcomes than mastectomy for early-stage patients ( Dr Sabine Siesling - Netherlands Comprehensive Cancer Organisation, Utrecht, Netherlands )

Mastectomy plus reconstruction has higher complication rates and costs than...

Prof Benjamin D. Smith - The University of Texas MD Anderson Cancer Center...

Mastectomy plus reconstruction has higher complication rates and costs than lumpectomy plus radiation ( Prof Benjamin D. Smith - The University of Texas MD Anderson Cancer Center, Houston, USA )

Resistance of ER-positive breast cancer to tamoxifen therapy may be driven by...

Dr Reuben Harris - Howard Hughes Medical Institute, Minneapolis, USA

Resistance of ER-positive breast cancer to tamoxifen therapy may be driven by APOBEC3B ( Dr Reuben Harris - Howard Hughes Medical Institute, Minneapolis, USA )

Denosumab improves disease-free survival for postmenopausal patients with HR...

Prof Michael Gnant - Medical University of Vienna, Vienna, Austria

Denosumab improves disease-free survival for postmenopausal patients with HR-positive breast cancer ( Prof Michael Gnant - Medical University of Vienna, Vienna, Austria )

Overexpression of the enzyme APOBEC3B is linked to somatic mutagenesis in...

Dr Reuben Harris - Howard Hughes Medical Institute, Chevy Chase, USA

Overexpression of the enzyme APOBEC3B is linked to somatic mutagenesis in breast and other cancers ( Dr Reuben Harris - Howard Hughes Medical Institute, Chevy Chase, USA )

Women with luminal A breast cancer subtype do not seem to benefit from adjuvant...

Dr Torsten Nielsen - University of British Columbia, Vancouver, Canada

Women with luminal A breast cancer subtype do not seem to benefit from adjuvant chemotherapy ( Dr Torsten Nielsen - University of British Columbia, Vancouver, Canada )

Denosumab improves disease-free survival for postmenopausal HR-positive breast...

Prof Michael Gnant - Medical University of Vienna, Vienna, Austria

Denosumab improves disease-free survival for postmenopausal HR-positive breast cancer ( Prof Michael Gnant - Medical University of Vienna, Vienna, Austria )

Women with luminal A subtype of breast cancer did not benefit from adjuvant...

Dr Torsten Nielsen - University of British Columbia, Vancouver, Canada

Women with luminal A subtype of breast cancer did not benefit from adjuvant chemotherapy ( Dr Torsten Nielsen - University of British Columbia, Vancouver, Canada )

Pathologic complete response to presurgery chemo improves survival for triple...

Dr William Sikov - Women & Infants Hospital of Rhode Island, Providence, USA

Pathologic complete response to presurgery chemo improves survival for triple-negative breast cancer ( Dr William Sikov - Women & Infants Hospital of Rhode Island, Providence, USA )

More from ecancer